NRTN and cancer: In pancreatic cancer, which is closely linked with neuropathic pain, NTN has been shown to be produced by cancer cells, and to increase the cells' biological properties, trigger neuroplastic alterations, neural invasion and influence pain sensation via the GFRA2 receptor (Wang et al., 2014).